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Abstract  
Clinical trials are expensive and time-consuming and so should also be used to study how treatments 
work. This would allow evaluation of theoretical treatment models and refinement and 
improvement of treatments. Treatment processes can be studied using mediation analysis. 
Randomised treatment makes some of the assumptions of mediation models plausible, but the 
mediator – outcome relationship remains one that can be subject to bias. In addition, mediation is 
assumed to be a temporally ordered longitudinal process, but most mediation studies to date have 
been cross-sectional and unable to explore this assumption. This study used longitudinal structural 
equation modelling of mediator and outcome measurements from the PACE trial of rehabilitative 
treatments for chronic fatigue syndrome (ISRCTN 54285094) to address these issues. In particular, 
autoregressive and simplex models were used to study measurement error in the mediator, 
different time lags in the mediator – outcome relationship, unmeasured confounding of the 
mediator and outcome, and the assumption of a constant mediator – outcome relationship over 
time. Results showed that allowing for measurement error and unmeasured confounding were 
important. Concurrent rather than lagged mediator – outcome effects were more consistent with 
the data, possibly due to the wide spacing of measurements. Assuming a constant mediator-
outcome relationship over time increased precision. 
 
Keywords: mediation, longitudinal mediation models, structural equation models, measurement 
error, clinical trials, chronic fatigue syndrome 
  
 3 
Introduction 
The primary objective of randomised clinical trials is to answer the question “does the treatment 
work”?  However, researchers generally have other important questions about treatment, such as 
how treatments work, and the testing of theoretical models of treatment mechanisms – essential 
knowledge for future therapeutic development. The case is especially strong when a trial shows no 
treatment differences, when it is often critical to obtain information about why the treatment failed. 
Trials are expensive and can be demanding for both patients and clinical staff. Answering questions 
beyond those of treatment effectiveness can be justified in terms of marginal cost, burden and 
ethics, and in many instances may require little more than additional analyses.. Such investigations 
often rely heavily on mediation analysis. While mediation analysis is in very common use, with one 
of the source works by Baron and Kenny having been cited more than 10,000 times, studies applying 
these methods rarely discuss the problems of variables measured with error and post-randomisation 
confounding. This paper describes how these problems can be addressed in a structural equation 
modelling framework. 
 
A mediation model is depicted at the bottom of Figure 1, each path labelled as is traditional for this 
field. Under  certain no unmeasured confounding assumptions, correct model specification and 
when the mediator and outcome are continuous, mediation can be assessed through a series of 
ordinary least squares regression equations where Y = outcome, M = mediator and R = randomly 
assigned treatment 
1
: 
 
111 iii RY εβα ++=   (1) 
222 iii RM εβα ++=  (2) 
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333 iiii MRY εγβα +++=  (3). 
 
β1 gives the total effect of treatment on outcome, referred to in the mediation literature as the c 
path. In the past it was suggested that mediation should only be assessed when this total effect was 
significant, but more recently we and others have argued that mediation should be assessed 
whether or not β1 is significant 
2-7
. In order for there to be mediation, β2 in equation 2 (a in Figure 1), 
should be significant; i.e. treatment has an effect on the mediator. In addition, in equation 3 which 
corresponds to b in Figure 1, γ should be significant, i.e. the mediator has an effect on the outcome. 
The indirect, or mediated, effect is then given by β2γ (or the product a times b), known as the 
product of coefficients (POC) estimate 
8
 .Any remaining direct effect of treatment on the outcome is 
given by β3, which is referred to as c’. In the situation where β1 is not significant, studying these 
relationships could clarify why the treatment was not effective. The estimated a path shows 
whether the treatment had any effect on the mediator, while the estimated b path  clarifies whether 
the mediator is predictive of the outcome. Non- significance of either of these estimates could partly 
explain the ineffectiveness of a treatment. Studying the a, b and c’ paths together will also indicate 
whether the direction of the c’ path or direct effect is different from that of the indirect effect. This 
is referred to as inconsistent mediation or suppression and can be associated with a non-significant 
overall effect 
3
. The POC mediated effect estimate is a simple example of the application of Sewell 
Wright’s path tracing rules, which takes the products of the estimates along each legal path between 
two variables and then sums the products across all of the paths
9, 10
. Paths cannot be traced: 1) 
where an arrow is first traced in a forward direction and the next arrow in a backwards direction, 2) 
through a variable more than once and 3) through more than one bidirectional arrow. It is important 
to note that this tracing and indirect effect calculation assumes linear relationships amongst the 
variables in the model and conditional multivariate normality
11, 12
. The models in (2) and (3) can be 
fitted simultaneously using the structural equation model (SEM) framework. We focus here on how 
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the framework allows some progress to be made in relation to two of the likely major sources of bias 
in mediation effect estimates, namely measurement error in the mediator and confounding of the 
mediator-outcome relationship. 
 
Classical measurement error in the mediator results in a bias towards zero in the estimate of the 
mediator, so-called attenuation or dilution
13
. The single mediator/single outcome model of Figure 1 
can account for measurement error if a good estimate of the reliability of the mediator is known 
14
, 
and other regression-based methods have also recently been applied to address this problem 
15, 
16
.However, SEM allows for the simultaneous estimation of multiple equations and with repeated or 
multivariate measurement this allows the incorporation of measurement error using latent 
variables
11, 12, 17
. The latent or “true score” is a hypothetical quantity relating to the error-free 
measure of the construct of interest, which is defined in practice from a decomposition of 
covariances 
11, 12
. In SEM with repeated measures this commonly follows a classical measurement 
error model, in which the variance of a measure is partitioned into a latent ‘true score’ and an 
additive error which is assumed conditionally independent 
11-13
. The error is assumed to be 
independent of this true latent mediator score given exposure  and covariates. The effect of a latent 
mediator variable on the outcome would provide an estimate of the mediator – outcome 
relationship disattenuated for measurement error 
11, 12
. 
 
 .  
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In randomised clinical trials,the mediator is not generally randomised, and as a consequence,  the 
relationship between the mediator and outcome could be subject to confounding 
3, 18-21
. The need to 
make the assumption of no unmeasured confounding has received much attention in the literature 
2, 
3, 22-30
. Extending the range of measured confounders is recommended but without the addition of an 
instrumental variable, which in practice is rarely available 
4, 14
, we cannot add an error covariance 
between mediator and outcome to the simple model of Figure 1 as the model will no longer be 
identified – there would be six parameters to estimate (three regression parameters, two error 
variances and an error covariance) and only five quantities available for estimation (two variances 
and three covariances). Quantifying parameter estimate sensitivity to unmeasured confounding 
provides another option. For example, Vanderweele describes general direct and indirect effects 
bias formulae for sensitivity analysis 
27
, while Imai and colleagues use the SEM framework as a 
starting point and provide methods to quantify the sensitivity of the mediator – outcome 
relationship to the correlation between mediator and outcome error terms 
23, 24
. With repeated 
measurement, we highlight that relaxation of the conditional independence assumption of SEM 
measurement models can allow for correlation among the measurement errors of mediator and 
outcome that some unmeasured confounders may induce. This has allowed us to take  a more 
model selection-based approach using model fit criteria and perusal of the effect of different SEM on 
the mediator – outcome relationship estimates.  Fitting different SEM in this way could be thought 
of another type of sensitivity analysis. This method has some advantages over other sensitivity 
analysis solutions that have been offered 
15, 16, 23, 24
,in that it allows for measurement error and 
unmeasured confounding in a single step, and unlike regression based methods, doesn’t require the 
provision of sensitivity parameters such as measurement reliability and measurement error variance 
15, 16
. Such parameters are likely to be difficult to estimate accurately. De Stavola and colleagues 
extended the sensitivity analyses described by Imai et al to the situation where there are 
confounders of the mediator and outcome that are affected by the treatment or “intermediate 
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confounders” 
22, 25, 26, 28, 29
. We make the assumption for the purposes of this paper that we have no 
“intermediate confounding”.. 
 
The study that motivated this work was the Pacing, Graded Activity, and Cognitive Behaviour 
Therapy: A Randomised Evaluation or PACE study of rehabilitative treatments for Chronic Fatigue 
Syndrome 
31
, which is described in more detail in the Methods section. In an initial study of 
mediation of the PACE treatments using the POC method 
3, 8
, the mid-treatment measurement of 
the mediators and the follow-up measure of outcomes showed that the effects of CBT and GET were 
partially mediated through cognitive and behavioural factors  
32
. However, this initial analysis did not 
take advantage of all the available repeated measures data. Mediation is regarded as a causal 
process, where the temporal ordering of treatment -> mediator -> outcome is implied. The repeated 
measures of mediator and outcome data in the PACE trial allow for exploration of time lags in 
mediated effects in addition to measurement error and unmeasured confounding. 
 
The aim of this work was to address issues affecting estimation and precision of the mediator – 
outcome relationship in longitudinal mediation models. These issues were: measurement error in 
the mediator, time lags of mediator – outcome relationship, unmeasured confounding and the 
assumption of a constant mediator – outcome relationship over time. The repeated measures of 
mediators and outcomes available in the PACE data were used to address this aim.  
 
Methods 
Motivating study 
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The PACE trial of treatments for chronic fatigue syndrome (CFS) randomised individuals to four 
treatment groups defined as three therapies each in addition to the control treatment, and the 
control treatment alone 
31
. The therapies were cognitive behavioural therapy (CBT), graded exercise 
therapy (GET), adaptive pacing therapy (APT), with the control being specialist medical care (SMC) 
delivered by a doctor with experience of treating CFS. CBT was delivered by psychotherapists and 
focused on examining the link between thoughts, behaviours and symptoms and negotiating 
behavioural and cognitive changes with the patient as appropriate. It was based on a fear avoidance 
model of CFS 
32
. GET was delivered by physiotherapists and involved a mutually agreed gradual 
increase in activity for the patient. It was based on deconditioning and exercise intolerance models 
of the illness. APT was delivered by occupational therapists. It was based on the model of a finite 
and limited amount of energy and advised participants to balance activity with rest. The trial found 
that CBT and GET were superior to APT and SMC for both physical functioning and fatigue outcomes. 
Measures of the mediators and outcomes were taken at baseline, mid-treatment (12 weeks post-
randomisation), post-treatment (24 weeks post-randomisation) and follow-up (52 weeks post-
randomisation). The West Midlands Multicentre Research Ethics Committee (MREC 02/7/89) 
approved the original PACE study, ISRCTN 54285094. This trial provides a unique opportunity to 
study longitudinal mediation given that most mediators were measured at all time points, the 
mediators and outcomes were measured mid-therapy, which is uncommon, and there were four 
treatment groups rather than the usual two treatment group design. The data on the subset of the 
participants randomised to receive CBT and APT were used for this analysis for simplicity. 
Advantages associated with the four treatment group design and longitudinal mediation results for 
all four treatment groups will be reported elsewhere.  
 
An example mediator, fear avoidance beliefs, and one of the two primary trial outcomes, self-rated 
physical functioning, were used in this study. Fear avoidance beliefs were measured using the 
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Cognitive Behavioural Responses Questionnaire 
33, 34
, which is a scale ranging from 0 to 24. Physical 
functioning was measured with the physical functioning subscale of the SF-36 
35, 36
, which ranges 
from 0 to 100. Fear avoidance beliefs were found to be the strongest mediator of the effect of CBT 
and GET as compared to APT in a simple single mediator/outcome POC analysis 
32
.  
 
Structural Equation Models 
Data were standardised using the mean and standard deviation (SD) of the baseline measure, so the 
units for the mediator – outcome estimates and indirect effects were  baseline physical functioning 
SDs. SEMs were used to model the longitudinal mediation and outcome processes. The only other 
covariate in the models was treatment group. Mplus version 7.2 was used to fit models; full 
information maximum likelihood was used, which estimates parameters using information from 
complete and incomplete records under a missing at random assumption 
37, 38
. Model fit was 
assessed using the chi-square test of model fit 
12
 and the root mean square error of approximation 
(RMSEA) 
39, 40
. Models were compared using informal comparison of the Chi-square statistic, RMSEA 
and the Bayesian Information Criterion (BIC) 
41
.  
 
Longitudinal Structural Equation Models for Mediation 
There are several longitudinal SEMs that could be applied in a mediation analysis, which have been 
reviewed by MacKinnon 
3
. One such model is a first-order autoregressive as shown in Figure 2A for a 
mediator process where measures have been taken at the time points in the PACE trial. The model 
assumes that: each variable is a function only of the measure of that variable at the previous time 
point (plus other covariates such as treatment group), there is no measurement error and 
correlations between the measurements decrease over time 
3, 42, 43
. This may or may not be a 
plausible assumption for the correlations of the mediator and outcome measurements in PACE. 
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When using such models for mediation, an autoregressive structure is fit to both the mediator and 
outcome processes separately and then these are linked together by estimates we will refer to 
hereafter as the b paths 
3
, as shown in Figure 3. The exposure of interest, here R or the randomised 
treatment group, is allowed to affect different measures of both the mediator and outcome. 
 
We explored the effects of the following on estimation and precision of the b1, b2 and b3 paths 
(Figure 3) within the autoregressive model structure:  
1) allowing for independent measurement error in the mediators to remove attenuation bias,  
2) allowing different b1, b2 and b3path time lags  
3) allowing for measurement error covariances between the mediator and outcome variables that 
would be induced by unmeasured confounding and which could attenuate or inflate the b1, b2 and b3 
path estimates and  
4) assuming equality of the b1, b2 and b3paths over time, which would be consistent with the view 
that no matter how or when the mediator is changed, its relationship with the outcome remains 
constant.  
 
Before reporting results we detail how each of these issues were addressed in the modelling. All the 
models leave the randomised treatment group to be uncorrelated with all other variables. 
 
Measurement error - Autoregressive versus simplex models 
Autoregressive models can be extended to allow for measurement error by fitting models with a 
quasi-simplex structure as shown in Figure 2B for the mediator process. The quasi- simplex model 
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(referred to as simplex hereafter) uses each observed value of the variable as a single indicator for a 
latent ‘true score’ variable with the autoregressive relationship for the variable then being between 
these true scores rather than the observed scores 
42-44
.In this way, classical measurement error is 
incorporated 
11-13
.So if for example we take the baseline mediator measure, M0, it is made up of the 
true measure, FM0, plus the conditionally independent error,  or M0 = FM0 + . One way to 
obtain identification of a simplex model with four measurements is to assume parallel measurement 
and set the factor loadings and error variances equal over time. This was the approach taken here. 
The importance of allowing for measurement error was assessed by comparing model fit of dual-
process autoregressive and simplex models fitted to both the mediator and outcome processes as 
shown in Figure 3, and by comparing the b path estimates and their standard errors informally (i.e. 
without using statistical tests). Figure 4 shows the equations associated with the model in Figure 3C, 
which assume classical measurement error
13
. 
 
Time lags of mediation paths – lagged and contemporaneous 
In each case, an autoregressive or simplex model was fitted with either lagged b1, b2 and b3paths 
between the mediator at the time point prior to the outcome at the time point immediately 
following, or contemporaneous b1, b2 and b3 paths between mediator and outcome at the same time 
point. Lagged paths respect the implied temporal ordering of change in mediator prior to change in 
outcome that would be expected for a causal process. Models with contemporaneous paths were 
also fitted despite their lack of allowance for temporal ordering as these sorts of relations were 
plausible, perhaps especially given the considerable lengths of time between measures. 
Autoregressive models with these two types of paths are shown in Figures 3A and 3B. Figures 3C and 
D show dual process simplex models with contemporaneous b1, b2 and b3 paths (the covariances are 
discussed in the next section). Models with lagged and contemporaneous b paths were compared 
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using the BIC and the other model fit indices and informal comparison of the b path estimates and 
their standard errors.  
 
Unmeasured confounding – lagged and contemporaneous measurement error covariances 
One plausible extension of the simplex model is to allow for covariance between measurement 
errors in the mediator and outcome. This covariance could be thought of as encompassing some 
type of unmeasured confounding that is captured by correlated measurement errors. This could be 
covariance in errors at the same time point – where factors on a given day are affecting 
measurement of both mediator and outcome, or covariance between an earlier measure of the 
mediator and a later measure of the outcome, where there is a more persistent process in play. Such 
paths can be allowed for when repeated measurements are available, as in Figure 3C and 3D, which 
show examples of models with contemporaneous and lagged covariances respectively. Models with 
different types of covariances were compared as described in the previous section on time lag of 
mediation paths.  
 
Precision of the b paths in longitudinal mediation models 
To potentially increase the precision of the b paths and also in the interest of model parsimony, 
evidence for setting the measurement error covariances to be equal over time and for setting the b1, 
b2 and b3 paths to be equal over time was examined. This was done using Wald chi-square tests for 
model constraints with the degrees of freedom equal to the number of parameter constraints 
tested. For the covariances this was initially a test of equality of four contemporaneous covariances 
or two post-baseline lagged covariances. If this test indicated a significant difference, pairwise tests 
were done to characterize the differences. For the b paths the Wald test was structured as a test of 
equality of either three contemporaneous paths (b1, b2 and b3) or two lagged paths (b2 and b3). 
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One other assumption was explored. Theoretically there may be no need for treatment to mediator 
(a3 path) and treatment to outcome (c’3 path) paths beyond the end of treatment. The need for 
these paths was assessed using a Wald chi-square test for these two paths being equal to zero. 
 
The assumptions were tested in the models in the order: equal measurement error covariances, 
need for a3 and c’3 paths and equality of b paths. If an assumption could be made, it was 
incorporated in models going forward. 
 
Calculation of indirect effects in longitudinal mediation models 
When we extend mediation models to the longitudinal case there are more indirect or mediated 
paths than the single path in the simple mediation model. In the in the simplex models we have 
fitted using the SEM framework, the mediated effects are straightforward to calculate using the path 
tracing rules described previously 
8-10, 21
. When assuming multivariate normality and linear 
relationships between variables 
11, 12
, this entails finding each path between two variables, 
multiplying together all parameter estimates on each path and then summing these products 
together. Cole and Maxwell point out the key issue of choosing the effects of interest in models with 
several measures of outcome over time, and suggest these will most likely focus on the final 
outcome time point, given that data have been gathered to that point for a clinical and/or 
theoretical reason 
21
. They describe “time-specific indirect effects”, which might have one of the 
earlier outcome time points as the time point of interest, and “overall indirect effects” which are the 
effects up to the final measurement. Indirect effects are those going through any measure of the 
mediator.  
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The main indirect/mediated effect of interest in the PACE example here is the overall indirect effect 
for the 52 week time point. In order to obtain this effect, all of the time-specific indirect effects 
would be calculated for that time point and summed together. An example of one of the time-
specific effects that would contribute to the overall indirect effect at 52 weeks in the model in Figure 
3A would be R -> M12 -> M24 -> M52 -> Y52 (calculated as a1 x m2 x m3 x b3). An example of a direct or 
non-mediated effect (does not pass through any measure of the mediator) would be R -> Y12 -> Y24 -> 
Y52 (calculated as c1 x y2 x y3 ). So, the total effect of the randomised treatment R on the final 
measure of Y52 would be: 
( )+⋅⋅⋅= 523243122152 MbMmMmRaY  (4) 
( )+⋅⋅⋅ 2432421221 YyMbMmRa  (5) 
( )+⋅⋅⋅ 2431221211 YyYyMbRa    (6) 
( )+⋅⋅ 5232432 MbMmRa    (7) 
( )+⋅⋅ 2432422 YyMbRa     (8) 
( )+⋅ 5233 MbRa     (9) 
( )+⋅⋅ 2431221 YyYyRc    (10) 
( )+⋅ 2432 YyRc     (11) 
( )Rc3      (12) 
Expressions (4) through (9) are time-specific indirect effects, which summed together, constitute the 
overall indirect effect. Expressions (10), (11) and (12) are three time-specific direct effects (for the 52 
week time point), which summed together, constitute the overall direct effect. The total effect can 
be obtained as shown by summing all effects, or by summing the overall indirect and direct effects. 
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These effects can be easily extended to the simplex models by replacing the observed variables by 
their latent true score counterparts. The target parameters are the same in the simplex and 
autoregressive models, but the estimates differ; in the case of the simplex model the parameters 
incorporate a model-based correction for measurement error. The indirect and direct effects can be 
assumed to be causal if there is no residual unmeasured confounding or measurement error, no 
“intermediate confounders”, the linearity and multivariate normality assumptions are met and the 
models are otherwise properly specified. While we focus here on making these assumptions and 
taking the SEM approach, causal estimators could be elucidated using potential outcomes, following 
on from the multiple causally ordered mediator estimands put forward by Daniel et al 
45
. CI for these 
effects were calculated using 1000 repetitions of the bias-corrected bootstrap 
46, 47
. 
 
Simulation study addressing the consequences of ignoring measurement error and unmeasured 
confounding 
Some model assumptions were addressed using simulations. Data were simulated and analysed 
using the Mplus MONTECARLO command. Data were generated under the following three models: 
1. Simplex model without measurement error or unmeasured confounding (error covariances) 
to approximate the autoregressive models (as in Figure 6C with ε = 1 x 10
-10
) 
2. Simplex model allowing for measurement error, no unmeasured confounding (error 
covariances, as in Figure 6C) 
3. Simplex model allowing for measurement error and unmeasured confounding (error 
covariances, as in Figure 6E). 
The data generated were then analysed under each of the three types of model in turn. The analyses 
with equivalent data generation and analysis models served as controls. The true parameter values 
were obtained by fitting the model of interest to the PACE data, saving the parameter estimates and 
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using them as the true estimates in the MONTECARLO program. The simulation study was based on 
the two group CBT versus APT comparison, with datasets of n = 50, 100, 320 (the number in two 
groups in the PACE trial), 640 (the number in four groups in the PACE trial) and 1000 were simulated, 
with 1500 repetitions in each case 
48
. Absolute bias was calculated by subtracting the true parameter 
values from the average parameter estimate across repetitions. Mean square error (MSE) and 
coverage across repetitions were obtained from the Mplus output. 
 
Results 
The model diagrams are shown in Figures 5 (lagged b paths) and 6 (contemporaneous b paths).  
 
Measurement error 
Model fit indices show that the simplex models fitted better than the comparable autoregressive 
models (Table 1), suggesting it was important to allow for measurement error. For example, for the 
models with contemporaneous b paths, the simplex model BIC minus the autoregressive model BIC 
was -24 (comparing Figure 6A and 6B). For the models with lagged b paths, accounting for 
measurement error had the expected disattenuation effect, i.e. the simplex model b paths were 
larger in magnitude (in Figure 5B versus Figure 5A and Supplementary Table A). However for models 
with contemporaneous b paths, the opposite was true (Figure 6B versus Figure 6A and 
Supplementary Table A). The effect of taking measurement error into account was also seen in the 
magnitude of paths between the previous measure of the mediator/outcome and the subsequent 
measure (i.e. the m and y paths in Figure 3C). These paths were of larger magnitude in the simplex 
models (for example, compare Figures 5A and 5B). Accounting for measurement error led to a small 
loss in precision (e.g. comparing the b paths from autoregressive model Figure 6A to simplex model 
Figure 6B, also see Figure 7).  
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Evidence suggested that the a3 and c’3 paths to the final outcome time point could be set equal to 
zero in the simplex models (p > 0.43 for all covariance/b path lag combinations), so they were set 
equal going forward. 
 
Time lags of mediation paths 
The BIC suggested that models with contemporaneous mediation paths fitted better than models 
with lagged paths (Table 1). For example, the BIC for the simplex model with contemporaneous b 
paths minus the BIC for the model with lagged b paths was -31 (comparing Figures 5C and 6C). The 
contemporaneous b paths were generally larger in magnitude than the lagged b paths (Figure 7 and 
Supplementary Table A). 
 
Unmeasured confounding 
In both the cases of the lagged and contemporaneous error covariances, the overall tests indicated 
that not all covariances could be assumed equal (p < 0.004 for lagged and p < 0.030 for 
contemporaneous). For the lagged covariances, there was no evidence that the 12 – 24 week and 24 
– 52 week covariances were different (p > 0.77), so these were set equal. For the contemporaneous 
covariances, the general pattern was that the baseline and 24 week covariances were of a smaller 
magnitude than those at 12 and 52 (data not shown). When considered from the point of view of 
unmeasured confounding there would seem little basis for a hypothesis of a constant covariance. 
However, when considered from a measurement model perspective a parsimonious model would 
suggest uniform covariances as plausible. The RMSEA and AIC were very similar in models with and 
without these covariances set equal, with the BIC being smaller in the models with equal 
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covariances. For example, the model shown in Figure 6E with equal contemporaneous covariances 
had a BIC difference of 7 when compared to a model where the covariances were freed (data not 
shown). Equal covariances were therefore used in models going forward. The covariances were 
generally statistically significant in models where they were set equal (see Figures 5D and E and 6D 
and E).  
 
The inclusion of contemporaneous error covariances had greater impact than the inclusion of lagged 
error covariances. For example, in the three models with lagged b paths in Figures 5C, D and E, the 
BICs for the models with no and with lagged error covariances were very similar (Table 1, Figure 5C 
compared to Figure 5D), however, the differences in BIC for the model with contemporaneous error 
covariances and the model with none was -64 (Table 1, Figure 5E compared to Figure 5C). There was 
a similar pattern for models with contemporaneous b paths. The only models with RMSEA values 
consistent with good model fit were those with contemporaneous error covariances (Table 1). In 
models with contemporaneous b paths, including contemporaneous covariances decreased the 
magnitude of the b path somewhat (comparing the models in Figures 6C and 6E, see also Figure 7). 
 
Precision of the b paths  
Tests for equality of b paths over time showed that these could be set equal both for lagged paths 
(for equality of b2 and b3 paths, p = 0.92 for model with lagged covariances, p = 0.84 for 
contemporaneous covariances) and contemporaneous paths (for equality of b1, b2 and b3 paths, p = 
0.13 for model with lagged covariances, p = 0.12 for contemporaneous covariances). Making this 
assumption of equal b paths at each time point gave a large precision gain; for example, comparing 
Figure 6B to 6C, the smallest standard error in Figure 6B with free b paths was 0.057 and in Figure 6C 
with a common b path was 0.030, giving a 47% relative increase in precision. Assuming equal error 
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covariances over time also increased the precision of the b path, but by only a small amount in most 
cases (data not shown).  
 
Type of covariances versus lag of b paths 
In the simplex model it appeared that the type of measurement error covariances was more 
important than the type of mediation paths. For example, in terms of model fit there was little to 
choose between the two models having contemporaneous covariances but different types of b paths 
in Figure 5E and 6E (Table 1). On the other hand, when comparing models with the same type of b 
paths but contemporaneous versus lagged covariances (for example, Figure 5E versus 5D), it is clear 
that the former fitted the data much better (Table 1).  
 
Best fitting model 
In summary, the most plausible model by RMSEA, AIC and BIC was the simplex with 
contemporaneous b paths and error covariances (Table 1 and Figure 6E). Because this model had no 
treatment to 52 week mediator or outcome paths it assumed no direct effect of treatment on 
physical functioning at 52 weeks, and that any residual effects of treatment had persisted from the 
post-treatment time point (24 weeks). 
 
Indirect effects in longitudinal simplex mediation models 
Figure 8 shows the total indirect/mediated effects for each time point, with more detail of the 
estimates and CI for the various time specific indirect, direct and total and overall effects in Tables B, 
C and D in the supplementary material. Figure 8 shows the smaller b paths in the lagged models led 
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to smaller indirect effects as would be expected. The figure also shows that using path analysis rules 
to calculate mediated effects from the simplex models gives effects that accumulate over time.  
 
The overall effect of treatment group on physical functioning at 52 weeks in the best fitting model 
with contemporaneous b paths and error covariances (Figure 6E) was 0.69 physical functioning SD 
units (95% CI 0.44, 0.95) (Figure 8 and Supplementary Table D). The time specific indirect/mediated 
effect for this time point indicated that CBT increased physical functioning through the fear 
avoidance mediator by 0.28 physical functioning SD units (0.15, 0.44) (Figure 8 and Supplementary 
Table D). This suggested that approximately 41% of the effect of treatment on physical functioning 
was mediated through fear avoidance when all repeated measures of both mediator and outcome 
were modelled and measurement error and unmeasured confounding were taken into account. 
 
The common b path assumption that led to greater precision in the b paths also led to greater 
precision in the indirect effects. In the model shown in Figure 6E, the standard error (SE) for the 52 
week indirect effect with this assumption was 0.068, giving a CI of 0.15 to 0.44 (Figure 8). If the 
common b path assumption was relaxed in this model the SE was 0.073 and CI 0.18 to 0.47.  
 
Consequences of ignoring measurement error and unmeasured confounding 
Figures 9 and 10 show the absolute bias, MSE and coverage results from the simulation study . Each 
simulation took 25 seconds or less to run using the Mplus program. Figure 9 shows effects of 
ignoring measurement error when it is present on the a1, a2, b, m2, m3, y2 and y3 paths and Figure 10 
shows the effect of ignoring measurement error and confounding when they are present on the 
same paths (the numeric data are available upon request). Models converged across most 
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repetitions in all conditions, with the exceptions occurring when n = 50 (Supplementary Table E). 
There were problems with the latent variable covariance matrix and the residual covariance matrix 
for simulations where data were generated and analysed with measurement error, which were 
alleviated in the case of larger sample sizes. There were also problems with the residual covariance 
matrix for simulations where data were generated without and analysed allowing for measurement 
error that did not dissipate with increasing sample size. There was little evidence of effects on bias, 
MSE and coverage when allowing for measurement error and unmeasured confounding in the case 
where these weren’t present (Supplementary Figure A  and Figure 9  middle row ).   However, there 
were issues with the statistical quantities for most of the paths of interest in the models when 
measurement error was present but  not accounted for (Figures 9 and 10, bottom rows) and to a 
lesser extent when only unmeasured confounding was ignored (Figure 10, middle row). The effects 
were somewhat worse when both measurement error and confounding were present and ignored 
(Figure 10, bottom row) as compared to measurement error alone (Figure 9, bottom row). .  Effects 
tended to be worse for the paths connecting the mediator and outcome measures through time, i.e. 
the m2, m3, y2 and y3 paths as shown in Figure 3C.  This is important because these paths contribute 
to longitudinal mediated effects (see Calculation of indirect effects in longitudinal mediation models 
section). 
Except for larger MSE values for the smallest sample sizes, increasing sample size did not generally 
alleviate problems with the estimates, and where bias did not improve, coverage worsened.  It was 
of note that the b path suffered from very poor coverage both when measurement error and 
confounding were ignored and also to a lesser extent when just confounding was ignored. 
Discussion 
The aim of this paper was to examine issues affecting the mediator – outcome relationship in a 
longitudinal mediational analysis of data from a trial of complex treatments for chronic fatigue 
syndrome. The paper focused specifically on measurement error in the mediator, time lags, 
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unmeasured confounding and the assumption of a constant mediator – outcome relationship over 
time. We found that it was clearly important to account for measurement error and unmeasured 
confounding, otherwise parameter estimates and mediated effects may be biased and inferences 
about estimates flawed. While lagged mediator – outcome paths would be more consistent with a 
causal effect, models with contemporaneous mediator – outcome relationships fitted better. 
Assuming a constant mediator – outcome relationship over time was plausible and brought a large 
gain in precision. Our findings here using longitudinal measures supported our earlier finding using a 
single measure of both mediator and outcome that fear avoidance mediated the effect of treatment 
on physical functioning 
32
.  
 
The superiority of the simplex over the autoregressive models and the results of the simulation 
study clearly showed it was important to account for measurement error in the mediator, perhaps 
more so than accounting for unmeasured confounding. Models with lagged mediator – outcome 
relationships followed the classical measurement error paradigm where error dampens effects and 
so taking account of it increased the magnitude of effects On the other hand, the contemporaneous 
mediator – outcome effects were smaller in the simplex models as compared to the autoregressive 
models. Complex effects of accounting for measurement error in multi-equation models have been 
noted previously 
11
. Measurement error was accounted for in this study by using the simplex models, 
but it is also important to try to do more to address this issue through improved measurement of 
mediators and outcomes..  
 
Accounting for measurement error led to a small loss in precision. Instrumental variables analysis 
(IV) is another method for coping with confounding and measurement error in predictor variables. It 
has proven difficult to apply IV methods to mediation analysis so far, mainly due to the absence of 
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strong instruments, leading to imprecise mediator – outcome estimates 
4, 14
. In our experience, the 
use of these repeated measures measurement error models as an alternative to IV has led to much 
smaller losses in precision.  
 
Lagged mediator – outcome relationships, which would be more consistent with the temporal 
ordering of a causal process such as mediation, were not supported in the PACE data. This could 
have been due to the apparent almost simultaneous change in mediator and outcome in these data 
31
. However, it could also be because the first measurement of the mediator was taken too late to 
capture mediator change prior to change in the outcome. The mid-treatment measurements were 
taken after participants had received approximately seven sessions of therapy, which may be quite 
late in the process of change. For example, evidence of gains in the first three sessions of brief 
psychosocial therapy interventions has been demonstrated for depression 
49
. Studies looking more 
carefully at the trajectories of mediator and outcome change by taking earlier and more frequent 
measures of the variables, perhaps even at every session of therapy, could clarify optimal timing and 
number of measurements.  
 
The potential for unmeasured confounding of the mediator – outcome relationship was allowed for 
in models through covariances between mediator and outcome errors. The best fitting models were 
those with contemporaneous error covariances, suggesting there were unmeasured confounders of 
the mediator and outcome variables at the same time point that needed to be taken into account. 
Lagged covariances would have been more consistent with unmeasured confounding in a typical 
‘simple’ mediator model with one measure of the mediator taken earlier acting on a single later 
measure of the outcome. There was less evidence for this sort of unmeasured confounding in the 
PACE data, although this may not be the case in other situations. Allowing for unmeasured 
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confounding is desirable given the attention this issue has been given in the literature, with the 
approach described here providing one option. More generally, in practice there is no single best 
approach and, for example, the approach here could be extended to incorporate existing sensitivity 
analysis methods 
22-24
 to quantify the level of confounding that would alter these longitudinal model 
conclusions.  
The assumption of equal mediator – outcome relationships over time led to greater precision in 
these estimates. The idea that no matter how or when the mediator is changed it will have the same 
effect on the outcome is a potentially strong and theoretically appealing assumption. This 
assumption aligns well with a description of mediation used in programme theory and intervention 
evaluation. These fields have described mediation analysis  as evaluating both an ‘action theory’ – 
the a path in Figure 1 where an intervention seeks to change a mediating variable, and a ‘conceptual 
theory’ – the b path in Figure 1, which is the causal relationship between the mediator and outcome 
50
. Describing the b path as the ‘conceptual theory’ fits with thinking of this as a stable relationship 
existing in nature that can be manipulated by the ‘action theory’ or intervention. This implies that 
the ‘conceptual theory’ relationship exists in the absence of the intervention and should exist at 
different points in time. The support of both action and conceptual theories provides evidence for 
mediation. From a statistical point of view, this assumption led to a large increase in mediator – 
outcome effect precision, which in turn led to more precise mediated effects. When plausible, 
making this assumption could be important given the often low power to detect mediated effects 
51
.  
 
The study’s strengths lay in the use of high quality data stemming from a rigorously conducted trial, 
as well as the availability of multiple measurements of mediators and outcomes allowing for more 
complex models. It was only possible to allow for unmeasured confounding in these models because 
of the availability of multiple measurements. The single measurement each of mediator and 
outcome generally used to evaluate mediation do not allow for fitting of a model with mediator - 
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outcome covariance as such a model is not identified. It is also more difficult to account for 
measurement error in these single measure models, although it can be done if the reliability of the 
measure is known. At least four measurements are needed for identification of all parameters in the 
simplex models. Clinical trials often only take baseline, post-treatment and follow-up measurements, 
but the mid-treatment measures taken in PACE made it possible to allow for more paths and to 
explore assumptions in models. Also, given the apparent simultaneous early change in mediators 
and outcomes in PACE 
32
 it may be fruitful to collect more measurements earlier in the process to 
clarify mediator and outcome trajectories. Having additional repeated measures of mediator and 
outcome and/or different measurements of the mediator and outcome at each time point could 
allow for the exploration of further model assumptions. Furthermore, the methods used here had 
some particular strengths. Much of the causal mediation literature has focused on the issue of 
unmeasured confounding, however, both the  simulation results in this study and previous 
mediation model results 
14
 suggest that in mental health measurement error may be of even greater 
concern than unmeasured confounding. The approach taken here addresses both measurement 
error and the induced unmeasured confounding that correlated measurement error can give rise to 
simultaneously , while avoiding the need to estimate complex sensitivity parameters.  As such, this 
approach provides for another type of sensitivity analysis. In addition, it is likely much easier to gain 
information about the reliability of measurement, such as we have done here using repeated 
measures, than it is in most situations to identify and measure all important confounders. This being 
said, we do not see the approach taken here and the sensitivity analyses described in the literature 
15, 16, 22-24
 as mutually exclusive. For example, the approaches using SEM to study sensitivity to 
unmeasured confounding 
22-24
 could be incorporated into the sorts of measurement models that we 
have fitted here.  
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Although there has been some criticism of the use of SEMs to model causal processes, these models 
have made a large contribution to the modern study of mediation and have been shown here and by 
others to be a very useful tool for this purpose 
52
. This study showed that modelling of multiple 
mediator and outcome measurements using SEMs provided flexibility and allowed for exploration of 
some important assumptions.  
 
There are some limitations of the study. One is that we didn’t adjust for other potential baseline 
confounders of the mediator and outcome besides the baseline measures of mediator and outcome. 
We included a larger list of measured confounders in the initial PACE mediation analysis and so are 
confident that the relationship between fear avoidance and physical function is robust to 
confounding 
32
. We would generally advise the inclusion of measured confounders, which requires 
consideration at the trial design stage. However, the baseline measures of the mediator and 
outcome are likely the most important confounders 
14
 and may also act as proxies for other 
confounders that haven’t been included. The longitudinal models used here included these as well 
as other measures of the mediator and outcome over time, which are also likely to be important 
confounders. Given this and the results of the initial mediation analysis 
32
, it seems unlikely the 
inclusion of other variables would have had a large effect on the mediation estimates. In another 
analysis (not shown), the variable with the largest effect on the relationship between the fear 
avoidance mediator and physical functioning outcome was baseline fear avoidance, with baseline 
work and social adjustment having  the second largest effect
4
. The latter variable changed the 
mediated effect by less than 0.06 units on the standardised scale. Given this, it seems unlikely that 
including work and social adjustment and other weaker confounders would negate the overall 
mediation effects found here. It is possible that measurement error covariances could be less 
important when more measured confounders are included, and it would be important to explore 
this. A further consideration in the interest of simplicity was the focus of this study on a subset of 
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PACE data also. However, these and other longitudinal models have been used to study the full 
extent of the PACE trial data and will be described in another paper. Finally, we have assumed that 
the data are missing at random, an assumption that may not have been met. However, the 
autoregressive and simplex models likely made this assumption more plausible as earlier measures 
of the mediator and outcome were predictors of later measures in the models. Future research 
could evaluate the effect of violation of this assumption on estimates of mediated effects. 
 
The simplex models offer advantages over the autoregressive models, including acknowledging 
measurement error. However, simplex models make some restrictive assumptions, such as assuming 
effects between different measurements of the same variable are only from the measure of that 
variable from the prior time point, as well as an autoregressive correlation structure 
42, 43
. These may 
or may not be plausible assumptions for the PACE data. In addition, the accumulation of mediated 
effects over time implied by these models may not be the best fit for the PACE data, where at least 
on average there was greater change in the mediator and outcome variables up to 12 weeks with a 
plateau afterwards 
31
. These issues may have been reflected in the model fit indices, which 
suggested that the best model shown here could still be improved upon. We will explore other 
model types that can allow for different assumptions, such as latent growth models that can allow 
for a trajectory for each process, and latent change models allowing for potentially independent 
directions of change between each time point 
42
  in another paper. 
 
In conclusion, longitudinal SEMs can account for important sources of potential bias in mediation 
analysis, such as measurement error in the mediator and unmeasured confounding. Optimal 
application of these methods requires the availability of repeated measures, necessitating 
consideration at the study design stage. Assuming that no matter how or when the mediator is 
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changed it has the same effect on the outcome is plausible and gains efficiency. Later phase clinical 
trials of treatments should aim to address mediation as well as effectiveness hypotheses, keeping in 
mind these analyses would be enhanced by the inclusion of more and earlier measurements of 
mediators and outcomes.  
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Figure 1. Treatment effect and mediation path diagrams 
 
 
R = randomised treatment, Y = outcome, M = mediator, U = unmeasured confounders 
 
Figure 2. Autoregressive and simplex model examples 
 
M0 = mediator at baseline, M12 = mediator at 12 weeks, M24 = mediator at 24 weeks, M52 = mediator 
at 52 weeks, FM0 = latent true mediator score at baseline, FM12 = latent true mediator score at 12 
weeks, FM24 = latent true mediator score at 24 weeks, FM52 = latent true mediator score at 52 
weeks. One method for obtaining identification of the model in B is shown in the figure: all var(ε) are 
set equal. 
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Figure 3. Autoregressive models with contemporaneous and lagged b paths and simplex models with contemporaneous and lagged covariances using PACE 
example time points 
M0, M12, M24, M52 – mediator measurements taken at baseline, 12 weeks, 24 weeks and 52 weeks post-randomisation. Y0, Y12, Y24, Y52 – outcome 
measurements taken at the same time points.
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Figure 4. Equations describing dual-process simplex model shown in Figure 3C 
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Models were fitted with mediator (M) error variances set equal (εM) and outcome (Y) error variances 
set equal (εY) 
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Figure 5. Longitudinal mediator – outcome process models with lagged b paths 
 
Numbers in tables are estimate (standard error). R = randomised treatment group, M0, M12, M24, M52 – mediator measurements taken at baseline, 12 
weeks, 24 weeks and 52 weeks post-randomisation,   Y0, Y12, Y24, Y52 – outcome measurements taken at the same time points, FM0, FM12, FM24, FM52 – true 
mediator scores at baseline, 12 weeks, 24 weeks, 52 weeks post-randomisation, FY0, FY12, FY24, FY52 – true outcome scores at the same time points. Paths 
between observed and latent variables for both the mediator and the outcome process all have factor loadings of 1.  
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Figure 6. Longitudinal mediator – outcome process models with contemporaneous b paths 
 
Numbers in tables are estimate (standard error). R = randomised treatment group, M0, M12, M24, M52 – mediator measurements taken at baseline, 12 
weeks, 24 weeks and 52 weeks post-randomisation,   Y0, Y12, Y24, Y52 – outcome measurements taken at the same time points, FM0, FM12, FM24, FM52 – true 
mediator scores at baseline, 12 weeks, 24 weeks, 52 weeks post-randomisation, FY0, FY12, FY24, FY52 – true outcome scores at the same time points. Paths 
between observed and latent variables for both the mediator and the outcome process all have factor loadings of 1. 
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Table 1. Comparison of fit statistics across autoregressive and simplex models  
General type Figure 
# 
Corr’n 
type 
Med’n 
type 
Model χ
2
 RMSEA  
(90% CI) 
AIC BIC 
Models without parameter restrictions
a
 
Autoregressive 5A N L 187.943 
 df =20 
 p < 0.001 
0.162 
 (0.141, 0.184)  
p < 0.001 
6633.276 6753.863 
Simplex 5B N L 115.696  
df =18 
 p < 0.001 
0.130 
 (0.108, 0.153)  
p < 0.001 
6565.030 6693.153 
Autoregressive 6A N C 123.004 
 df =20 
 p < 0.001 
0.127 
 (0.106, 0.149)  
p < 0.001 
6568.337 6688.924 
Simplex 6B N C 87.706 
 df =18 
 p < 0.001 
0.110 
 (0.088, 0.134)  
p < 0.001 
6537.039 6665.162 
Models with parameter restrictions
a
 
Simplex 5C N L 117.023  
df =21 
 p < 0.001 
0.120 
 (0.099, 0.141)  
p < 0.001 
6560.356 6677.174 
Simplex 6C N C 91.916 
 df =22 
 p < 0.001 
0.100 
 (0.079, 0.121)  
p < 0.001 
6533.249 6646.299 
Simplex 5D L L 106.322 
 df =19 
 p < 0.001 
0.120 
 (0.098, 0.143)  
p < 0.001 
6553.655 6678.010 
Simplex 5E C L 47.051 
 df =20 
 p = 0.001 
0.065 
 (0.041, 0.089)  
p = 0.14 
6492.384 6612.970 
Simplex 6D L C 82.252 
 df =20 
 p < 0.001 
0.099 
 (0.077, 0.121)  
p < 0.001 
6527.585 6648.171 
Simplex 6E C C 41.383 
 df =21 
 p = 0.005 
0.055 
 (0.030, 0.080)  
p = 0.34 
6484.717 6601.534 
χ
2
 = chi-square model fit statistic, RMSEA = root mean square error of approximation, CI = 
confidence interval, AIC = Akaike’s Information Criterion, BIC = Bayesian Information Criterion, N = 
no post-baseline covariances, C = contemporaneous, L = lagged, df = degrees of freedom 
a
Parameter restrictions are equal error variances for each mediator measure and for each outcome 
measure, treatment to mediator at 52 weeks and treatment to outcome at 52 weeks = 0 and 
mediator to outcome b paths equal over time  
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Figure 7. b paths (95% CI) for autoregressive and simplex models 
AUTO = autoregressive model, SIM = simplex model, N = no post-baseline covariances, L = lagged, C 
= contemporaneous, NONE = covariances free, treatment to 52 week paths present, mediation b 
paths not set equal, REST = covariances set equal, treatment to 52 week paths = 0, mediation b 
paths set equal, w = weeks post-randomisation, ES = estimate, CI = confidence interval 
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Figure 8. Overall indirect/mediated effects (95% bias-corrected bootstrap CI) for simplex models  
 
L = lagged, C = contemporaneous, w = weeks post-randomisation, ES = estimate, CI = 95% bias-
corrected bootstrap confidence interval 
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Figure 9. Simulation results – effect of ignoring measurement error when present 
 
All data generated using simplex models and 1500 repetitions for each sample size, allowing for 
measurement error (ME), but not for measurement error covariances representing unmeasured 
confounding (Conf). MSE = mean square error, Control = generated and analysed allowing for ME 
only when only ME present, Allow for ME & Conf = analysed allowing for both ME and Conf when 
only ME present, Allow for neither = analysed without allowing for ME or Conf when only ME 
present. . 
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Figure 10. Simulation results – effect of ignoring measurement error and confounding when present 
 
All data generated using simplex models and 1500 repetitions for each sample size allowing for 
measurement error (ME) and for measurement error covariances representing unmeasured 
confounding (Conf). MSE = mean square error, Control = generated and analysed with ME and Conf 
when both ME & Conf present, Allow for ME only = analyse allowing ME only when both ME & Conf 
present, Allow for neither = analysed without allowing for ME or Conf when both ME & Conf 
present.  
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Supplementary Material 
Table A. Comparison of b path estimates (SE) across autoregressive and simplex models 
Figure # Corr’n 
type 
Med’n 
type 
BL -> 
12 
weeks 
b path 
12 -> 
24 
weeks 
b path 
24 -> 
52 
weeks 
b path 
12 -> 
12 
weeks 
b path 
24 -> 
24 
weeks 
b path 
52 -> 
52 
weeks 
Autoregressive 
Figure 5A N L -0.063 
(0.059) 
-0.021 
(0.049) 
-0.032 
(0.056) 
--- --- --- 
Simplex 
Figure 5B N L -0.100 
(0.081) 
-0.080 
(0.063) 
-0.049 
(0.072) 
--- --- --- 
Autoregressive 
Figure 6A N C --- --- --- -0.305
a
 
(0.055) 
-0.180
a
 
(0.045) 
-0.242
a
 
(0.052) 
Simplex 
Figure 6B N C --- --- --- -0.260
a
 
(0.066) 
-0.079 
(0.057) 
-0.192
a
 
(0.064) 
Simplex with restrictions 
Figure 5C N L -0.099 
(0.079) 
-0.065 
(0.038) 
-0.065 
(0.038) 
--- --- --- 
Figure 6C N C --- --- --- -0.163
a
 
(0.030) 
-0.163
a
 
(0.030) 
-0.163
a
 
(0.030) 
Figure 5D L L -0.227
a
 
(0.091) 
-0.071 
(0.040) 
-0.071 
(0.040) 
--- --- --- 
Figure 5E C L -0.194
a
 
(0.079) 
-0.075
a
 
(0.037) 
-0.075
a
 
(0.037) 
--- --- --- 
Figure 6D L C --- --- --- -0.175
a
 
(0.030) 
-0.175
a
 
(0.030) 
-0.175
a
 
(0.030) 
Figure 6E C C --- --- --- -0.122
a
 
(0.028) 
-0.122
a
 
(0.028) 
-0.122
a
 
(0.028) 
SE = standard error, BL = baseline, N = no post-baseline covariances, L = lagged, C = 
contemporaneous 
a
estimate significant at p ≤ 0.05. 
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Table B. Time-specific indirect, direct and total effects at 12 weeks (95% bias-corrected bootstrap CI) in fear avoidance/physical functioning simplex models 
with restrictions 
 Figure 5D Figure 5E Figure 6D Figure 6E 
Covariance type L C L C 
Mediation type L L C C 
Indirect effects: 
trt -> fm12 -> fy12   0.130 (0.082, 0.203) 0.090 (0.051, 0.146) 
Total 12 week indirect effect    0.130 (0.082, 0.203) 0.090 (0.051, 0.146) 
Direct effects:     
trt -> fy12 0.483 (0.229, 0.749) 0.483 (0.231, 0.745) 0.348 (0.117, 0.607) 0.385 (0.152, 0.628) 
Total 12 week direct effect  0.483 (0.229, 0.749) 0.483 (0.231, 0.745) 0.348 (0.117, 0.607) 0.385 (0.152, 0.628) 
Total 12 week effect  0.483 (0.229, 0.749) 0.483 (0.231, 0.745) 0.478 (0.219, 0.735) 0.475 (0.223, 0.725) 
L = lagged, C = contemporaneous, fm12 = latent true mediator score at 12 weeks, fy12 = latent true outcome score at 12 weeks 
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Table C. Time-specific indirect, direct and total effects at 24 weeks (95% bias-corrected bootstrap CI) in fear avoidance/physical functioning simplex models 
with restrictions 
 Figure 5D Figure 5E Figure 6D Figure 6E 
Covariance type L C L C 
Mediation type L L C C 
Indirect effects: 
trt -> fm12 -> fy24 0.053 (-0.002, 0.123) 0.055 (-0.002, 0.118)   
trt -> fm12 -> fy12 -> fy24   0.125 (0.080, 0.184) 0.090 (0.050, 0.142) 
trt -> fm12 -> fm24 -> fy24   0.115 (0.073, 0.177) 0.088 (0.047, 0.141) 
trt -> fm24 -> fy24   0.031 (-0.001, 0.077) 0.012 (-0.009, 0.045) 
Total 24 week indirect effect  0.053 (-0.002, 0.123) 0.055 (-0.002, 0.118) 0.272 (0.171, 0.410) 0.191 (0.106, 0.304) 
Direct effects:     
trt -> fy12 -> fy24 0.482 (0.232, 0.755) 0.490 (0.236, 0.772) 0.334 (0.110, 0.604) 0.385 (0.159, 0.664) 
trt -> fy24 0.090 (-0.119, 0.282) 0.069 (-0.150, 0.270) 0.020 (-0.186, 0.213) 0.033 (-0.179, 0.229) 
Total 24 week direct effect  0.572 (0.308, 0.831) 0.560 (0.298, 0.828) 0.354 (0.100, 0.612) 0.419 (0.170, 0.663) 
Total 24 week effect  0.625 (0.385, 0.882) 0.615 (0.364, 0.867) 0.625 (0.385, 0.880) 0.610 (0.365, 0.862) 
L = lagged, C = contemporaneous, fm12 = latent true mediator score at 12 weeks, fm24 = latent true mediator score at 24 weeks, fy12 = latent true 
outcome score at 12 weeks, fy24 = latent true outcome score at 24 weeks 
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Table D. Time-specific indirect, direct and total effects at 52 weeks (95% bias-corrected bootstrap CI) in fear avoidance/physical functioning simplex models 
with restrictions 
 Figure 5D Figure 5E Figure 6D Figure 6E 
Covariance type L C L C 
Mediation type L L C C 
Indirect effects: 
trt -> fm12 -> fy24 -> fy52 0.053 (-0.002, 0.121) 0.056 (-0.001, 0.117)   
trt -> fm12 -> fm24 -> fy52 0.050 (-0.002, 0.127) 0.055 (-0.0002, 0.128)   
trt -> fm24 -> fy52 0.009 (-0.002, 0.036) 0.007 (-0.005, 0.034)   
trt -> fm12 -> fy12-> fy24 -> fy52   0.119 (0.079, 0.171) 0.089 (0.051, 0.137) 
trt -> fm12 -> fm24-> fy24 -> fy52   0.109 (0.071, 0.157) 0.087 (0.048, 0.136) 
trt -> fm12 -> fm24-> fm52 -> fy52   0.098 (0.062, 0.149) 0.078 (0.042, 0.127) 
trt -> fm24-> fy24 -> fy52   0.030 (-0.0004, 0.069) 0.012 (-0.009, 0.044) 
trt -> fm24-> fm52 -> fy52   0.026 (-0.001, 0.063) 0.011 (-0.009, 0.038) 
Total 52 week indirect effect  0.112 (-0.006, 0.260) 0.117 (-0.002, 0.255) 0.382 (0.247, 0.556) 0.278 (0.154, 0.435) 
Direct effects:     
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 Figure 5D Figure 5E Figure 6D Figure 6E 
Covariance type L C L C 
Mediation type L L C C 
trt -> fy12 -> fy24 -> fy52 0.479 (0.236, 0.780) 0.494 (0.239, 0.794) 0.317 (0.109, 0.582) 0.382 (0.160, 0.666) 
trt -> fy24 -> fy52 0.090 (-0.118, 0.285) 0.070 (-0.146, 0.276) 0.019 (-0.175, 0.201) 0.033 (-0.171, 0.232) 
Total 52 week direct effect  0.569 (0.306, 0.841) 0.564 (0.305, 0.840) 0.335 (0.092, 0.594) 0.415 (0.160, 0.655) 
Total 52 week effect  0.681 (0.432, 0.942) 0.682 (0.427, 0.944) 0.717 (0.490, 0.998) 0.692 (0.441, 0.953) 
L = lagged, C = contemporaneous, fm12 = latent true mediator score at 12 weeks, fm24 = latent true mediator score at 24 weeks, fm52 = latent true 
mediator score at 52 weeks, fy12 = latent true outcome score at 12 weeks, fy24 = latent true outcome score at 24 weeks, fy52 = latent true outcome score 
at 52 weeks 
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Table E. 
Simulation 
convergence 
results 
Generating 
model 
 Analysis 
model 
 Sample 
size 
Convergence Covariance 
matrix 
issues 
Measurement 
error 
Unmeasured 
confounding 
Measurement 
error 
Unmeasured 
confounding 
   
N N N N 50 1500/1500 0 
    100 1500/1500 0 
    320 1500/1500 0 
    640 1500/1500 0 
    1000 1500/1500 0 
N N Y N 50 1500/1500 Most 
    100 1500/1500 Most 
    320 1500/1500 Most 
    640 1500/1500 Most 
    1000 1500/1500 Most 
N N Y Y 50 1499/1500 Most 
    100 1500/1500 Most 
    320 1500/1500 Most 
    640 1500/1500 Most 
    1000 1500/1500 Most 
Y N N N 50 1500/1500 0 
    100 1500/1500 0 
    320 1500/1500 0 
    640 1500/1500 0 
    1000 1500/1500 0 
Y N Y N 50 1499/1500 Most 
    100 1500/1500 Many 
    320 1500/1500 1 (0.1%) 
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Table E. 
Simulation 
convergence 
results 
Generating 
model 
 Analysis 
model 
 Sample 
size 
Convergence Covariance 
matrix 
issues 
Measurement 
error 
Unmeasured 
confounding 
Measurement 
error 
Unmeasured 
confounding 
   
    640 1500/1500 0 
    1000 1500/1500 0 
Y N Y Y 50 1499/1500 Most 
    100 1500/1500 Many 
    320 1500/1500 0 
    640 1500/1500 0 
    1000 1500/1500 0 
Y Y N N 50 1500/1500 0 
    100 1500/1500 0 
    320 1500/1500 0 
    640 1500/1500 0 
    1000 1500/1500 0 
Y Y Y N 50 1496/1500 Most 
    100 1500/1500 Many 
    320 1500/1500 18 (1.2%) 
    640 1500/1500 1 (0.1%) 
    1000 1500/1500 0 
Y Y Y Y 50 1498/1500 Most 
    100 1500/1500 Many 
    320 1500/1500 25 (1.7%) 
    640 1500/1500 0 
    1000 1500/1500 0 
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Figure A. Simulation results – effect of accounting for measurement error and confounding when not 
present 
All data generated using simplex models not allowing for measurement error (ME), nor for 
measurement error covariances representing unmeasured confounding (Conf). MSE = mean square 
error, Control = generated and analysed without ME and Conf when both ME & Conf absent, Allow 
for ME only = analyse allowing ME only when both ME & Conf absent, Allow for both = analysed 
without allowing for ME or Conf when both ME & Conf absent. 
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